Preparation method of gene and hydrophobic drug co-supported PEG (polyethyleneglycol) nanoparticles

A hydrophobic drug and nanoparticle technology, which is applied in gene therapy, drug combination, pharmaceutical formulation and other directions, can solve problems such as affecting gene transfection efficiency, reducing the circulation time of gene delivery system, etc., and achieves simple and easy preparation method, easy operation, and easy loading capacity. The effect of adjusting and improving stability

Inactive Publication Date: 2012-10-03
ZHEJIANG UNIV
View PDF1 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this kind of polycation/DNA assembly is easy to aggregate in the body, and is cleared out of the body by the reticuloendothel

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of gene and hydrophobic drug co-supported PEG (polyethyleneglycol) nanoparticles
  • Preparation method of gene and hydrophobic drug co-supported PEG (polyethyleneglycol) nanoparticles
  • Preparation method of gene and hydrophobic drug co-supported PEG (polyethyleneglycol) nanoparticles

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0020] The steps of a method for preparing PEGylated nanoparticles co-loaded with genes and hydrophobic drugs are as follows:

[0021] 1) Prepare a β-cyclodextrin modified polycation solution with a concentration of 0.5-4 mg / mL;

[0022] 2) Prepare ferrocene-modified polyethylene glycol solution with a concentration of 0.5-4 mg / mL;

[0023] 3) Mix the solutions of step 1) and step 2) so that the molar ratio of β-cyclodextrin to ferrocene is 4:1-2:1, and then stand still after ultrasonication for 30 min;

[0024] 4) Prepare a hydrophobic drug solution with a concentration of 2 mg / mL;

[0025] 5) Add the hydrophobic drug solution prepared in step 4) dropwise to the solution in step 3), so that the molar ratio of β-cyclodextrin to hydrophobic drug is 1:1~1:4, stir in the dark for 24 hours, and dialyze for 8~ 24h, lyophilized to obtain β-cyclodextrin modified polycation / ferrocene modified polyethylene glycol / hydrophobic drug inclusion compound powder;

[0026] 6) Prepare β-cycl...

Example Embodiment

[0030] Example 1:

[0031] Prepare a β-cyclodextrin-modified polyethyleneimine (PEI-g-CD) solution with a concentration of 4 mg / mL and a ferrocene-modified polyethylene glycol (PEG-Fc) solution with a concentration of 4 mg / mL. The two solutions were mixed according to the molar ratio of β-CD and PEG-Fc in PEI-g-CD at a ratio of 2:1, sonicated for 30 min and left to stand for use. Add 2 mg / mL doxorubicin (DOX) dimethyl sulfoxide solution dropwise to the above mixed solution so that the molar ratio of CD and DOX in PEI-g-CD is 1:1, and stir in the dark for 24 h, then dialyzed for 8 h to 24 h, and freeze-dried to obtain PEI-g-CD / PEG-Fc / DOX clathrate powder. The PEI-g-CD / PEG-Fc / DOX clathrate powder prepared as above was used to measure the drug loading and encapsulation efficiency of doxorubicin (DOX) by ultraviolet-visible spectrophotometer (UV). The content was 9%, and the encapsulation efficiency was 57%, which indicated that β-cyclodextrin modified polyethyleneimine could ef...

Example Embodiment

[0033] Example 2:

[0034] Prepare a solution of β-cyclodextrin-modified polylysine (PLL-g-CD) with a concentration of 2 mg / mL and a solution of ferrocene-modified polyethylene glycol (PEG-Fc) with a concentration of 2 mg / mL. The two solutions were mixed according to the molar ratio of β-CD and PEG-Fc in PLL-g-CD as 3:1, and then left to stand after ultrasonication for 30 min. Add 2 mg / mL paclitaxel (PTX) chloroform solution dropwise to the above mixed solution, so that the molar ratio of CD and PTX in PLL-g-CD is 1:2, stir for 24 h in the dark, and then dialyze for 8 h ~24 h, lyophilized to obtain PLL-g-CD / PEG-Fc / PTX clathrate powder. Prepare a PLL-g-CD / PEG-Fc / PTX solution with a concentration of 0.5 mg / mL and a p16 (multiple tumor suppressor 1 gene) solution with a concentration of 75 μg / mL. The above-mentioned PLL-g-CD / PEG-Fc / PTX solution was mixed with 250 μL DNA solution in equal volume by vortexing and allowed to stand for 30 min to prepare PEGylated nanoparticles co-l...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of gene and hydrophobic drug co-supported PEG (polyethyleneglycol) nanoparticles. The method comprises the following steps of: 1) preparing beta-cyclodextrin modified polycation solution; 2) preparing ferrocene modified polyethylene glycol solution; 3) mixing solutions in step 1) and step 2), standing after ultrasound is carried out; 4) preparing a hydrophobic drug solution; 5) dripping the hydrophobic drug solution prepared in step 4) into the solution in step 3), stirring away from light, dialyzing and lyophilizing to obtain inclusion powder; 6) preparing an inclusion solution; 7) preparing a DNA (deoxyribonucleic acid) solution; and 8) adding the solution in step 6) to isovolumetric solution in step 7), performing eddy mixing and standing to obtain the gene and hydrophobic drug co-supported PEG nanoparticles. The gene and hydrophobic drug co-supported PEG nanoparticles prepared by virtue of a host-guest effect; and the preparation method is simple and easy in operation, so that the stability of the gene and hydrophobic drug co-supported PEG nanoparticles in physiological salt solution can be remarkably improved.

Description

technical field [0001] The invention relates to a method for preparing PEGylated nanoparticles co-loaded with genes and hydrophobic drugs. It combines gene therapy and chemotherapy, and belongs to the preparation method and technology of a new type of high-efficiency non-viral gene delivery system in the field of gene therapy. Background technique [0002] Cancer (malignant tumor) has become an important disease affecting human health due to the lack of effective treatment methods, and tens of billions of dollars are directly used for tumor treatment every year. Cancer has become one of the most stubborn fortresses that scientists have not yet conquered, and it is also one of the most challenging topics in contemporary scientific research. Chemotherapy is one of the important means of comprehensive treatment of malignant tumors. However, due to the large amount of drugs used and the lack of specificity, it can cause serious toxic and side effects to normal human cells whil...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/14A61K47/40A61K47/34A61K48/00A61K31/704A61K31/337A61P35/00
Inventor 王幽香陈丽娜李文宇唐三
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap